BAYNES ROY D. sold 21.1% of their position (10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $330.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/7/2026ACC: 0001680739-26-000003
-10K
Net shares
Net seller
$330.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$26.52
Trade value
$265.20K
% of position
26.7%
4/6/2026
37.50K→47.50K
Common Stock
Direct
Shares
−10K
Price / share
$33.00
Trade value
$330K
% of position
21.1%
4/6/2026
47.50K→37.50K
Total
Net shares
+0.00
Net value
-$64.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/6/2026 | M · Option Exercise | +10K | $26.52 | $265.20K | 26.7% | 37.50K | 47.50K |
| Common Stock Direct | 4/6/2026 | S · Sale | −10K | $33.00 | $330K | 21.1% | 47.50K | 37.50K |
| Total | +0.00 | -$64.80K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
26.52
Held after
0.00
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock10K shares | 4/6/2026 | M · Option Exercise | −10K | 26.52 | — | 0.00 |